Hospital-Acquired Anemia: A Contemporary Review of Etiologies and Prevention Strategies

  title={Hospital-Acquired Anemia: A Contemporary Review of Etiologies and Prevention Strategies},
  author={N. Martin and D. Scantling},
  journal={Journal of Infusion Nursing},
Advances in medicine have significantly improved lives and life spans globally. However, these practices have come with their own set of secondary consequences. Hospital-acquired anemia is one such consequence and is conferred by new medicines, operations, procedures, and tests. In this review, the authors will explore the data on this poorly considered phenomenon and discuss the etiologies, outcomes, and prevention strategies for some of the more prolific causes of hospital-acquired anemia… Expand

Topics from this paper

Incidence, Predictors, and Outcomes of Hospital‐Acquired Anemia
Severe HAA is associated with increased odds for 30‐day mortality and readmission after discharge; however, it is uncertain whether severe H AA is preventable. Expand
Anemia in hospitalized patients: an overlooked risk in medical care
This study investigated the association between nadir anemia and mortality and length of stay (LOS) in a general population of hospitalized patients.
Transfusion-related Acute Lung Injury in the Perioperative Patient.
Anesthesiologists need to consider transfusion-related acute lung injury in the perioperative setting, identify at-risk patients, recognize early signs of transfusions-related severe lung injury, and have established strategies for its prevention and treatment. Expand


Anemia in critical illness: insights into etiology, consequences, and management.
Normal red blood cell physiology; etiologies of anemia in the intensive care unit; its association with adverse outcomes; and the risks, benefits, and efficacy of various management strategies, including blood transfusion, erythropoietin, blood substitutes, iron therapy, and minimization of diagnostic phlebotomy are reviewed. Expand
Economic burden of anemia in an insured population.
Examination of anemia prevalence and associated medical costs and utilization, using administrative claims for adults newly diagnosed with anemia, including up to 12 months of follow-up, concludes that anemia is a common hematological disorder characterized by reduced hemoglobin concentrations. Expand
Economic burden of anemia in an insured population.
Medical costs for anemic patients are as much as twice those for nonanemic patients with the same comorbid conditions, including chronic kidney disease and cancer, using administrative claims for adults newly diagnosed with anemia. Expand
Efficacy of red blood cell transfusion in the critically ill: A systematic review of the literature*
In adult, intensive care unit, trauma, and surgical patients, RBC transfusions are associated with increased morbidity and mortality and therefore, current transfusion practices may require reevaluation. Expand
Hospital-acquired anemia and in-hospital mortality in patients with acute myocardial infarction.
Moderate and severe HAAs are independently associated with higher in-hospital mortality during acute myocardial infarction and increased with HAA severity. Expand
Update in critical care for the nephrologist: transfusion in nonhemorrhaging critically ill patients.
Strong evidence exists that a hemoglobin threshold of less than 7 g/dL conserves resources and may improve outcomes in critically ill patients and that platelet counts greater than 10,000/μL are well tolerated. Expand
Anemia, bleeding, and blood transfusion in the intensive care unit: causes, risks, costs, and new strategies.
  • M. McEvoy, A. Shander
  • Medicine
  • American journal of critical care : an official publication, American Association of Critical-Care Nurses
  • 2013
The types and causes of anemia, the increased health care utilization and costs associated with anemia and undetected internal bleeding, and the potential benefits and risks associated with transfusion of red blood cells also are explored. Expand
Do blood tests cause anemia in hospitalized patients?
Phlebotomy is highly associated with changes in hemoglobin and hematocrit levels for patients admitted to an internal medicine service and can contribute to anemia, which may have significant consequences for patients with cardiorespiratory diseases. Expand
Immune hemolytic anemia caused by drugs
DIIHA is often poorly investigated and many reports do not provide data to support the diagnosis, so it is important to exclude DIIHA in such patients as the only treatment needed is to discontinue the drug. Expand
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
Data from the head-to-head trials suggest an advantage of aprotinin over the lysine analogues TXA and EACA in terms of reducing perioperative blood loss, but the differences were small. Expand